Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases

Identifieur interne : 002265 ( Main/Exploration ); précédent : 002264; suivant : 002266

Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases

Auteurs : Gil Klinger [Canada] ; Yair Morad [Canada] ; Carol A. Westall [Canada] ; Carl Laskin [Canada] ; Karen A. Spitzer [Canada] ; Gideon Koren [Canada] ; Shinya Ito [Canada] ; Raymond J. Buncic [Canada]

Source :

RBID : ISTEX:0D6C97353512CBEBA76BBDB8FF1E76D6C8D5A824

English descriptors

Abstract

Summary: Chronic use of chloroquine and hydroxychloroquine in the treatment of rheumatic disease carries a small risk of sight-threatening pigmentary retinopathy. To obtain safety data for its use in pregnancy, we did ophthalmic examinations in 21 children born to women who took these drugs during pregnancy. Average daily maternal doses of the two drugs were 317 mg hydroxychloroquine and 332 mg chloroquine. The mean duration of gestational exposure was 72 months. No ophthalmic abnormality was detected in these children. Therapeutic use of these drugs during pregnancy may not pose a significant risk of ocular toxicity to offspring.

Url:
DOI: 10.1016/S0140-6736(01)06004-4


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases</title>
<author>
<name sortKey="Klinger, Gil" sort="Klinger, Gil" uniqKey="Klinger G" first="Gil" last="Klinger">Gil Klinger</name>
</author>
<author>
<name sortKey="Morad, Yair" sort="Morad, Yair" uniqKey="Morad Y" first="Yair" last="Morad">Yair Morad</name>
</author>
<author>
<name sortKey="Westall, Carol A" sort="Westall, Carol A" uniqKey="Westall C" first="Carol A" last="Westall">Carol A. Westall</name>
</author>
<author>
<name sortKey="Laskin, Carl" sort="Laskin, Carl" uniqKey="Laskin C" first="Carl" last="Laskin">Carl Laskin</name>
</author>
<author>
<name sortKey="Spitzer, Karen A" sort="Spitzer, Karen A" uniqKey="Spitzer K" first="Karen A" last="Spitzer">Karen A. Spitzer</name>
</author>
<author>
<name sortKey="Koren, Gideon" sort="Koren, Gideon" uniqKey="Koren G" first="Gideon" last="Koren">Gideon Koren</name>
</author>
<author>
<name sortKey="Ito, Shinya" sort="Ito, Shinya" uniqKey="Ito S" first="Shinya" last="Ito">Shinya Ito</name>
</author>
<author>
<name sortKey="Buncic, Raymond J" sort="Buncic, Raymond J" uniqKey="Buncic R" first="Raymond J" last="Buncic">Raymond J. Buncic</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:0D6C97353512CBEBA76BBDB8FF1E76D6C8D5A824</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1016/S0140-6736(01)06004-4</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-L364SQJS-P/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000013</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000013</idno>
<idno type="wicri:Area/Istex/Curation">000013</idno>
<idno type="wicri:Area/Istex/Checkpoint">001088</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001088</idno>
<idno type="wicri:doubleKey">0140-6736:2001:Klinger G:ocular:toxicity:and</idno>
<idno type="wicri:Area/Main/Merge">002289</idno>
<idno type="wicri:Area/Main/Curation">002265</idno>
<idno type="wicri:Area/Main/Exploration">002265</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases</title>
<author>
<name sortKey="Klinger, Gil" sort="Klinger, Gil" uniqKey="Klinger G" first="Gil" last="Klinger">Gil Klinger</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>The Motherisk Programme, Division of Clinical Pharmacology and Toxicology, Department of Pediatrics University of Toronto, Toronto</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Morad, Yair" sort="Morad, Yair" uniqKey="Morad Y" first="Yair" last="Morad">Yair Morad</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Ophthalmology, Hospital for Sick Children, University of Toronto, Toronto</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Westall, Carol A" sort="Westall, Carol A" uniqKey="Westall C" first="Carol A" last="Westall">Carol A. Westall</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Ophthalmology, Hospital for Sick Children, University of Toronto, Toronto</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Laskin, Carl" sort="Laskin, Carl" uniqKey="Laskin C" first="Carl" last="Laskin">Carl Laskin</name>
<affiliation wicri:level="4">
<orgName type="university">Université de Toronto</orgName>
<country>Canada</country>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Spitzer, Karen A" sort="Spitzer, Karen A" uniqKey="Spitzer K" first="Karen A" last="Spitzer">Karen A. Spitzer</name>
<affiliation wicri:level="4">
<orgName type="university">Université de Toronto</orgName>
<country>Canada</country>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Koren, Gideon" sort="Koren, Gideon" uniqKey="Koren G" first="Gideon" last="Koren">Gideon Koren</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>The Motherisk Programme, Division of Clinical Pharmacology and Toxicology, Department of Pediatrics University of Toronto, Toronto</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ito, Shinya" sort="Ito, Shinya" uniqKey="Ito S" first="Shinya" last="Ito">Shinya Ito</name>
<affiliation wicri:level="1">
<country wicri:rule="url">Canada</country>
</affiliation>
<affiliation wicri:level="4">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>The Motherisk Programme, Division of Clinical Pharmacology and Toxicology, Department of Pediatrics University of Toronto, Toronto</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Buncic, Raymond J" sort="Buncic, Raymond J" uniqKey="Buncic R" first="Raymond J" last="Buncic">Raymond J. Buncic</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Ophthalmology, Hospital for Sick Children, University of Toronto, Toronto</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">The Lancet</title>
<title level="j" type="abbrev">LANCET</title>
<idno type="ISSN">0140-6736</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="2001">2001</date>
<biblScope unit="volume">358</biblScope>
<biblScope unit="issue">9284</biblScope>
<biblScope unit="page" from="813">813</biblScope>
<biblScope unit="page" to="814">814</biblScope>
</imprint>
<idno type="ISSN">0140-6736</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0140-6736</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Abnormality</term>
<term>Acuity</term>
<term>Canadian institute</term>
<term>Chloroquine</term>
<term>Colour</term>
<term>Cystic</term>
<term>Cystic fibrosis</term>
<term>First trimester exposure</term>
<term>Frcs</term>
<term>Health research</term>
<term>Heart lung transplant</term>
<term>Hydrochloroquine</term>
<term>Hydroxychloroquine</term>
<term>Koren</term>
<term>Lancet</term>
<term>Lancet publishing group</term>
<term>Liver disease</term>
<term>Liver transplantation</term>
<term>Motherisk programme</term>
<term>Ocular toxicity</term>
<term>Ophthalmological</term>
<term>Ophthalmological abnormalities</term>
<term>Ophthalmological examination</term>
<term>Pigmentary retinopathy</term>
<term>Pregnancy outcome</term>
<term>Programme</term>
<term>Rheumatoid arthritis</term>
<term>Risk factors</term>
<term>Sick children</term>
<term>Systemic lupus erythematosus</term>
<term>Toxicity</term>
<term>Transplant</term>
<term>Transplantation</term>
<term>Visual abnormalities</term>
<term>Visual acuity</term>
<term>Visual fields</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Summary: Chronic use of chloroquine and hydroxychloroquine in the treatment of rheumatic disease carries a small risk of sight-threatening pigmentary retinopathy. To obtain safety data for its use in pregnancy, we did ophthalmic examinations in 21 children born to women who took these drugs during pregnancy. Average daily maternal doses of the two drugs were 317 mg hydroxychloroquine and 332 mg chloroquine. The mean duration of gestational exposure was 72 months. No ophthalmic abnormality was detected in these children. Therapeutic use of these drugs during pregnancy may not pose a significant risk of ocular toxicity to offspring.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
<region>
<li>Ontario</li>
</region>
<settlement>
<li>Toronto</li>
</settlement>
<orgName>
<li>Université de Toronto</li>
</orgName>
</list>
<tree>
<country name="Canada">
<region name="Ontario">
<name sortKey="Klinger, Gil" sort="Klinger, Gil" uniqKey="Klinger G" first="Gil" last="Klinger">Gil Klinger</name>
</region>
<name sortKey="Buncic, Raymond J" sort="Buncic, Raymond J" uniqKey="Buncic R" first="Raymond J" last="Buncic">Raymond J. Buncic</name>
<name sortKey="Ito, Shinya" sort="Ito, Shinya" uniqKey="Ito S" first="Shinya" last="Ito">Shinya Ito</name>
<name sortKey="Ito, Shinya" sort="Ito, Shinya" uniqKey="Ito S" first="Shinya" last="Ito">Shinya Ito</name>
<name sortKey="Koren, Gideon" sort="Koren, Gideon" uniqKey="Koren G" first="Gideon" last="Koren">Gideon Koren</name>
<name sortKey="Laskin, Carl" sort="Laskin, Carl" uniqKey="Laskin C" first="Carl" last="Laskin">Carl Laskin</name>
<name sortKey="Morad, Yair" sort="Morad, Yair" uniqKey="Morad Y" first="Yair" last="Morad">Yair Morad</name>
<name sortKey="Spitzer, Karen A" sort="Spitzer, Karen A" uniqKey="Spitzer K" first="Karen A" last="Spitzer">Karen A. Spitzer</name>
<name sortKey="Westall, Carol A" sort="Westall, Carol A" uniqKey="Westall C" first="Carol A" last="Westall">Carol A. Westall</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002265 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002265 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:0D6C97353512CBEBA76BBDB8FF1E76D6C8D5A824
   |texte=   Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021